Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT04453137 · COMPLETED
Trial details
- NCT number
- NCT04453137
- Sponsor
- Alvotech Swiss AG
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2021-05-31
- Enrollment
- 567
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.